Mark J.A. Schoonderwoerd
About Mark J.A. Schoonderwoerd
Mark J.A. Schoonderwoerd is a Senior Medical Science Liaison at Bristol Myers Squibb and Co-Founder of Levels Diagnostics, with a strong background in oncology, cardiovascular, and immunology therapeutic areas.
Current Positions
Mark J.A. Schoonderwoerd is currently working as a Senior Medical Science Liaison at Bristol Myers Squibb in Utrecht, Nederland. He also serves as a Co-Founder at Levels Diagnostics in Leiden. Both roles involve significant contributions to medical science and diagnostic innovation.
Previous Work Experience
Mark has an extensive work history in medical and research institutions. He was a PhD Student at Leiden University Medical Center from 2016 to 2020, a Trainee at the same institution from 2014 to 2016 and from 2013 to 2014, and a Trainer at District Sassenheim from 2013 to 2017. He also gained experience as a Trainee at Saltro for 4 months in 2011, at the University of Sheffield for 4 months from 2010 to 2011, and at ACTA in Amsterdam for 1 year from 2009 to 2010.
Educational Background
Mark studied at Leiden University, achieving a Master of Biology with a focus on Animal Biology and Disease Models from 2014 to 2016. He also holds a Bachelor of Applied Science (B.A.Sc.) in Clinical Laboratory Science/Medical Technology from Hogeschool Leiden, which he pursued from 2011 to 2014. Before this, he completed an MBO in Clinical Laboratory Science/Medical Technology at ROC Midden Nederland from 2007 to 2011.
Specializations and Interests
Mark focuses on oncology, cardiovascular, and immunology therapeutic areas. At Bristol Myers Squibb, he is responsible for immuno-oncology in genitourinary cancers such as renal cell carcinoma and urothelial carcinoma, as well as skin cancers like melanoma. He has a strong interest in novel approaches for cancer treatment, particularly using immuno-oncology targets.
Scientific Contributions and Achievements
Mark has received several grants and awards for his work as a PhD student and as a co-founder of Levels Diagnostics. He is also a co-author of multiple scientific publications. His efforts include providing medical information and resources to healthcare providers, engaging in biopharmaceutical research, and advocating for policies that promote health equity. Additionally, he supports patient access to medications through various programs and initiatives, aiming to improve care access for underserved patients.